Growth


 Regis Healthcare (ASX:REG) earnings forecasts fuel renewed growth-stock interest

Regis Healthcare (ASX:REG) earnings forecasts fuel renewed growth-stock interest

July 07, 2026 10:15 PM AEST| By Samta

Healthcare shares are regaining market attention as Regis Healthcare and Pro Medicus highlight the importance of resilient earnings, structural industry demand and long-term growth themes within Australia's healthcare sector.

 Why SKS Technologies (ASX:SKS) is on growth stock watchlists this week

Why SKS Technologies (ASX:SKS) is on growth stock watchlists this week

July 07, 2026 10:13 PM AEST| By Sam

SKS Technologies is gaining attention as expanding earnings expectations, digital infrastructure demand and a growing project pipeline strengthen its profile among Australia's technology-focused listed companies despite broader market uncertainty.

 Broker buy ratings put Catapult (ASX:CAT) and Netwealth (ASX:NWL) in growth spotlight

Broker buy ratings put Catapult (ASX:CAT) and Netwealth (ASX:NWL) in growth spotlight

July 07, 2026 10:11 PM AEST| By Sam

Catapult Sports and Netwealth continue attracting attention through technology-led business models, recurring revenue, expanding customer bases and long-term industry trends that are shaping Australia's evolving growth company landscape.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/shutterstock_2485562987_05_08_2026_10_44_18_523344.jpg

This ASX Growth Stock Has Tripled Profit in Three Years — And It’s Still Expanding

May 08, 2026 10:43 AM AEST| By Aditi Sarkar

HUB24 Limited (ASX:HUB) has increasingly positioned itself among the ASX’s closely watched financial technology growth companies as rising platform inflows, expanding funds under administration, and steadyEarningsgrowth continue reshaping its scale within Australia’sWealth Managementsector.

 Pro Medicus (ASX:PME): Why Are Growth Stocks Facing a Health Tech Test?

Pro Medicus (ASX:PME): Why Are Growth Stocks Facing a Health Tech Test?

July 07, 2026 08:38 PM AEST| By Sam

ASX growth stocks are drawing attention as health tech compounders build, with Pro Medicus, Xero, REA Group and Seek shaping the earnings runway screen.

 Why Is Pro Medicus (ASX:PME) Leading the ASX Growth Stocks Conversation?

Why Is Pro Medicus (ASX:PME) Leading the ASX Growth Stocks Conversation?

July 07, 2026 03:11 PM AEST| By Sam

Australia's growth stocks remain in focus as Pro Medicus, Xero, REA Group and Seek highlight the importance of platform retention, recurring revenue and operational execution.

 Is HUB24 Entering a New Growth Chapter After Its Board Refresh?

Is HUB24 Entering a New Growth Chapter After Its Board Refresh?

July 07, 2026 03:01 PM AEST| By Sam

Explore how HUB24's latest board appointment, platform expansion, governance strategy, valuation outlook, and industry trends are shaping investor attention across Australia's wealth management technology landscape.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/shutterstock_2449223297_05_07_2026_07_17_53_603121.jpg

This ASX Growth Stock Is Quietly Building an AI Commerce Empire

May 07, 2026 07:16 AM AEST| By Aditi Sarkar

Some technology companies grow by chasing trends. Others become embedded inside the infrastructure that industries rely on every single day.

 Why Is Pro Medicus (ASX:PME) Leading the ASX Growth Stocks Conversation?

Why Is Pro Medicus (ASX:PME) Leading the ASX Growth Stocks Conversation?

July 07, 2026 11:52 AM AEST| By Sam

ASX growth stocks remain in focus as Pro Medicus, Xero, REA Group and Seek highlight how customer retention, operational discipline and sustainable earnings are shaping market attention.

 What Could PEXA (ASX:PXA) and ASX 200 Stocks Reveal After a Tough Year?

What Could PEXA (ASX:PXA) and ASX 200 Stocks Reveal After a Tough Year?

July 07, 2026 10:24 AM AEST| By Sam

PEXA and Netwealth continue attracting attention as technology-led Australian businesses strengthen their digital platforms while operating across property services and wealth management amid changing market conditions.

 Why Are Genesis Minerals (ASX:GMD), Life360 (ASX:360) and REA Group (ASX:REA) Back on Broker Watchlists?

Why Are Genesis Minerals (ASX:GMD), Life360 (ASX:360) and REA Group (ASX:REA) Back on Broker Watchlists?

July 07, 2026 09:46 AM AEST| By Sam

Genesis Minerals, Life360 and REA Group continue advancing strategic initiatives across mining, technology and digital property, reinforcing their positions among Australia's closely watched growth-focused listed companies.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/shutterstock_2487464913_05_04_2026_06_04_57_780663.jpg

Australian Tech Shares: Growth Stocks Back in Focus in 2026

May 04, 2026 06:03 AM AEST| By Aditi Sarkar

ASX tech shares experienced significant gains during thePandemic-era rally, supported by accelerated digital adoption and ampleLiquidity. The subsequent rate-cycle pressure produced sharp valuation compression, particularly in long-duration growth names. The cohort entered a multi-year period of rebuilding.

 Top Growth Stocks to Watch: Xero (ASX:XRO) Leads the Quality Reset

Top Growth Stocks to Watch: Xero (ASX:XRO) Leads the Quality Reset

July 06, 2026 07:48 PM AEST| By Sam

Quality growth repair is reshaping Australia's growth sector by prioritising recurring revenue, disciplined expansion and operational execution, placing Xero, REA Group, Pro Medicus and TechnologyOne back under close market attention.

 Top Healthcare Growth Stocks to Watch: Pro Medicus (ASX:PME) Leads the Shift

Top Healthcare Growth Stocks to Watch: Pro Medicus (ASX:PME) Leads the Shift

July 06, 2026 07:36 PM AEST| By Sam

Healthcare growth rotation is reshaping Australia's market by rewarding companies demonstrating clinical demand, operational execution, margin discipline and international expansion, with Pro Medicus, ResMed, Cochlear and Neuren Pharmaceuticals remai...

 Pro Medicus (ASX:PME): Why Are ASX 200 Growth Stocks Back in Focus?

Pro Medicus (ASX:PME): Why Are ASX 200 Growth Stocks Back in Focus?

July 06, 2026 07:34 PM AEST| By Sam

Pro Medicus and REA Group have returned to market focus as business expansion, technology leadership and changing market sentiment reshape discussion around Australia's leading growth companies.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/shutterstock_1854622555_05_04_2026_05_48_03_320291.jpg

ASX Tech Share Forecast: Broker Sees Major Upside for One Growth Stock

May 04, 2026 05:46 AM AEST| By Aditi Sarkar

An ASX tech share has been pushed back into focus after fresh broker commentary outlined a meaningful upside case over the next twelve months. Tech remains one of the most discussed corners of the local market, with investors weighing rapid growth against the higherVolatilitythat …

 Why Is SKS Technologies (ASX:SKS) Winning Bigger Projects Across Australia?

Why Is SKS Technologies (ASX:SKS) Winning Bigger Projects Across Australia?

July 06, 2026 04:42 PM AEST| By Sam

SKS Technologies continues expanding through commercial project wins, growing data centre opportunities and stronger operational capacity, reinforcing its position within Australia's evolving engineering and technology services sector.

 Why These ASX 200 Leaders Continue to Capture Long-Term Attention

Why These ASX 200 Leaders Continue to Capture Long-Term Attention

July 06, 2026 02:48 PM AEST| By Sam

Explore why Commonwealth Bank and TechnologyOne continue attracting attention across the Australian share market through strong business models, customer loyalty, innovation, and long-term growth strategies.

 Why Is Life360 (ASX:360) Back in Focus Ahead of Its Next Update?

Why Is Life360 (ASX:360) Back in Focus Ahead of Its Next Update?

July 06, 2026 01:20 PM AEST| By Sam

Life360 remains in focus ahead of its next quarterly update as its expanding technology platform, subscription services and global user base continue to shape attention across Australia's technology sector.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/shutterstock_2259576441_05_04_2026_05_14_28_849071.jpg

ASX Growth Share Draws Broker Attention on Expansion and Earnings Outlook

May 04, 2026 05:12 AM AEST| By Aditi Sarkar

Broker upside views generally combineValuation Analysiswith growth assumptions. A discountedCash Flowapproach estimates the present value of future cash flows under specified scenarios, while multiple-based approaches compare current trading multiples to peers and historical ranges. Sensitivity analyses reveal how small changes in inputs can shift …

 Which ASX Growth Companies With High Insider Ownership Are Worth Watching?

Which ASX Growth Companies With High Insider Ownership Are Worth Watching?

July 06, 2026 10:48 AM AEST| By Sam

Guzman y Gomez and MA Financial Group continue pursuing long-term expansion strategies supported by meaningful insider ownership, reinforcing their positions within Australia's evolving consumer and financial services sectors.

 Why Are NextDC (ASX:NXT), Pro Medicus and Xero Emerging as AI Leaders?

Why Are NextDC (ASX:NXT), Pro Medicus and Xero Emerging as AI Leaders?

July 06, 2026 10:17 AM AEST| By Sam

Artificial intelligence is reshaping Australian technology, with NextDC, Pro Medicus and Xero expanding infrastructure, healthcare software and cloud accounting capabilities that support the growing adoption of AI across industries.

 3 ASX 200 Shares (ASX:STO), (ASX:PXA), (ASX:ALL) Back in Focus for FY2027

3 ASX 200 Shares (ASX:STO), (ASX:PXA), (ASX:ALL) Back in Focus for FY2027

July 04, 2026 07:07 PM AEST| By Sam

Santos, PEXA and Aristocrat Leisure continue drawing attention as energy expansion, digital property infrastructure and gaming technology innovation highlight several long-term themes shaping Australia's listed market.

Sponsored
 Why Is Pro Medicus (ASX:PME) Back in the Spotlight as the ASX 200 Recovers?

Why Is Pro Medicus (ASX:PME) Back in the Spotlight as the ASX 200 Recovers?

July 03, 2026 06:48 PM AEST| By Sam

Pro Medicus has re-emerged as one of Australia's standout healthcare technology companies as improving market sentiment and renewed interest in quality businesses drive attention back towards resilient, globally focused software providers.

 Xero (ASX:XRO) Leads ASX Growth Stocks as Quality Takes Centre Stage

Xero (ASX:XRO) Leads ASX Growth Stocks as Quality Takes Centre Stage

July 03, 2026 03:43 PM AEST| By Sam

Australia's growth stock narrative is shifting towards profitable expansion, with Xero, WiseTech Global, Pro Medicus and TechnologyOne highlighting the market's renewed emphasis on earnings quality and resilient business execution.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.